Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

OMEGA HEALTHCARE INVESTORS INC (OHI) Form 8-K — Jul 29, 2026

$OHIForm 8-KItems 2.02, 9.01Filed Jul 29, 2026, 4:17 PM ET0000888491-26-000022Original filing

Omega Healthcare Investors reported strong second quarter 2026 results, with Adjusted Funds From Operations (AFFO) of $0.83 per share, up from $0.77 in the prior year period. The company raised its full-year 2026 AFFO guidance to a range of $3.22 to $3.26 per share, citing accretive investment activity and active portfolio management. The company completed $126 million in new investments during the quarter and significantly expanded its partnership with Saber Healthcare. Additionally, Omega sold 26 facilities for $562.6 million in gross proceeds, recognizing a gain of $246.5 million, which bolstered its balance sheet and allowed for further capital deployment.

Key figures

Eps
1.19
Fad
0.78
Affo
0.83
Revenue
328246000
Guidance
$3.22 to $3.26
Net Income
379668000
Total Debt
4100000000
Cash Position
39036000
Offering Price
0
Shares Outstanding
299111000
Q2 asset sales
$562.6 million
Q2 investments
$126.5 million
Q2 dividend declared
$0.68

Price after filing

1 day: +0.5%7 days: -5.3%30 days: -9.9%

Close on the filing date to close N calendar days later (from $51.40). Historical, not a forecast.

AI analysis

Red flags2 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    OMEGA HEALTHCARE INVESTORS INC (OHI) Form 8-K — Jul 29, 2026: AI Analysis | Signal8